As of 2025-05-14, the Fair Value of Mirum Pharmaceuticals Inc (MIRM) is -8.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 45.27 USD, the upside of Mirum Pharmaceuticals Inc is -119.64%.
With the market price of 45.27 USD and our fair value calculation, Mirum Pharmaceuticals Inc (MIRM) is not a good investment. Investing in MIRM stocks now will result in a potential loss of 119.64%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -103.27 | -83.99 | -135.67 | -163.41 | -87.94 | -114.86 |
| YoY growth | -96.52% | 18.67% | -61.53% | -20.45% | 46.18% | -22.73% |
| Market Cap (mil) | 2,238.60 |
| P/E | |
| Forward P/E |
| EPS | -1.78 |
| Avg earnings growth rate | -22.73% |
| TTM earnings | -87.94 |